![John Rothman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Rothman
Directeur Technique/Scientifique/R&D chez
RIZE ONCOLOGY INC.
Fortune : 14 470 $ au 30/04/2025
Profil
John M.
Rothman is Chief Scientific Officer at Rize Oncology, Inc. since 2025.
Former positions include Senior Director at Schering-Plough Canada, Inc., EVP-Clinical & Scientific Operations at Advaxis, Inc. from 2011 to 2013, Chief Scientific Officer at Racura Oncology Ltd., and Executive Vice President-Product Development at Tyme Technologies, Inc. from 2020 to 2022.
Education includes a doctorate from Tulane University School of Medicine.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
RIZE ONCOLOGY INC. 1,32% | 06/01/2025 | 1 000 000 ( 1,32% ) | 14 470 $ | 30/04/2025 |
Postes actifs de John Rothman
| Sociétés | Poste | Début |
|---|---|---|
| RIZE ONCOLOGY INC. | Directeur Technique/Scientifique/R&D | 09/01/2025 |
Anciens postes connus de John Rothman
| Sociétés | Poste | Fin |
|---|---|---|
| TYME TECHNOLOGIES, INC. | Corporate Officer/Principal | 01/02/2022 |
| RACURA ONCOLOGY LTD | Directeur Technique/Scientifique/R&D | 01/10/2019 |
| AYALA PHARMACEUTICALS, INC. | Directeur des opérations | 09/12/2011 |
Schering-Plough Canada, Inc.
 Schering-Plough Canada, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical preparations | Directeur/Membre du Conseil | - |
Formation de John Rothman
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
24
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Tyme Technologies, Inc.
 Tyme Technologies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops cancer metabolism-based therapeutics | Health Technology |
Advaxis, Inc.
 Advaxis, Inc. Pharmaceuticals: MajorHealth Technology Develops immunotherapies for cancer and infectious diseases | Health Technology |
Schering-Plough Canada, Inc.
Schering-Plough Canada, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical preparations | Health Technology |
Tulane University School of Medicine
 Tulane University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Race Oncology Ltd.
 Race Oncology Ltd. Pharmaceuticals: MajorHealth Technology Manufactures drugs for cancer | Health Technology |
GeneTether Therapeutics, Inc.
 GeneTether Therapeutics, Inc. BiotechnologyHealth Technology Develops gene editing therapies and platform | Health Technology |
